102 related articles for article (PubMed ID: 28236518)
1. An Out-of-Pocket Cost Removal Intervention on Fecal Occult Blood Test Attendance.
Tabuchi T; Murayama H; Hoshino T; Nakayama T
Am J Prev Med; 2017 Aug; 53(2):e51-e62. PubMed ID: 28236518
[TBL] [Abstract][Full Text] [Related]
2. Does removal of out-of-pocket costs for cervical and breast cancer screening work? A quasi-experimental study to evaluate the impact on attendance, attendance inequality and average cost per uptake of a Japanese government intervention.
Tabuchi T; Hoshino T; Nakayama T; Ito Y; Ioka A; Miyashiro I; Tsukuma H
Int J Cancer; 2013 Aug; 133(4):972-83. PubMed ID: 23400833
[TBL] [Abstract][Full Text] [Related]
3. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
4. Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort.
Weber MF; Banks E; Ward R; Sitas F
J Med Screen; 2008; 15(3):137-42. PubMed ID: 18927096
[TBL] [Abstract][Full Text] [Related]
5. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea.
Bae N; Park S; Lim S
Eur J Oncol Nurs; 2014 Feb; 18(1):72-7. PubMed ID: 24183583
[TBL] [Abstract][Full Text] [Related]
8. Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study.
Lisi D; Hassan C; Crespi M;
Dig Liver Dis; 2010 May; 42(5):371-6. PubMed ID: 19747888
[TBL] [Abstract][Full Text] [Related]
9. Fecal occult blood testing: people in Ontario are unaware of it and not ready for it.
Ritvo P; Myers R; Del Giudice ME; Pazsat L; Cotterchio M; Howlett R; Mai V; Brown P; Sullivan T; Rabeneck L
Can Fam Physician; 2009 Feb; 55(2):176-177.e4. PubMed ID: 19221081
[TBL] [Abstract][Full Text] [Related]
10. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
[TBL] [Abstract][Full Text] [Related]
11. Adherence to and predictors of participation in colorectal cancer screening with faecal occult blood testing in Spain, 2009-2011.
Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López-de-Andrés A
Eur J Cancer Prev; 2015 Jul; 24(4):305-12. PubMed ID: 25304027
[TBL] [Abstract][Full Text] [Related]
12. Utilization of fecal occult blood test in the acute hospital setting and its impact on clinical management and outcomes.
Mosadeghi S; Ren H; Catungal J; Yen I; Liu B; Wong RJ; Bhuket T
J Postgrad Med; 2016; 62(2):91-5. PubMed ID: 27089107
[TBL] [Abstract][Full Text] [Related]
13. Financial incentives for completion of fecal occult blood tests among veterans: a 2-stage, pragmatic, cluster, randomized, controlled trial.
Kullgren JT; Dicks TN; Fu X; Richardson D; Tzanis GL; Tobi M; Marcus SC
Ann Intern Med; 2014 Nov; 161(10 Suppl):S35-43. PubMed ID: 25402401
[TBL] [Abstract][Full Text] [Related]
14. Cost Effectiveness of Colorectal Cancer Screening Interventions with Their Effects on Health Disparity Being Considered.
Lee KS; Park EC
Cancer Res Treat; 2016 Jul; 48(3):1010-9. PubMed ID: 26727714
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in FOBT use: evidence from a large German survey.
Sieverding M; Matterne U; Ciccarello L
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S47-51. PubMed ID: 18368645
[TBL] [Abstract][Full Text] [Related]
16. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
[TBL] [Abstract][Full Text] [Related]
17. Third Annual Fecal Occult Blood Testing in Community Health Clinics.
Arnold CL; Rademaker A; Wolf MS; Liu D; Hancock J; Davis TC
Am J Health Behav; 2016 May; 40(3):302-9. PubMed ID: 27103409
[TBL] [Abstract][Full Text] [Related]
18. Trends in colorectal cancer testing among Medicare subpopulations.
Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer screening in LHU4 Chiavarese, Italy: ethical, methodological and outcome evaluations at the end of the first round.
Ferrari Bravo M; De Conca V; Devoto GL; Sironi M; Mele R; Fumagalli A; Rimassa P; Rossi G; Zampogna A; Sticchi C; Gabutti G;
J Prev Med Hyg; 2012 Mar; 53(1):37-43. PubMed ID: 22803318
[TBL] [Abstract][Full Text] [Related]
20. Strategies to improve repeat fecal occult blood testing cancer screening.
Davis TC; Arnold CL; Bennett CL; Wolf MS; Reynolds C; Liu D; Rademaker A
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):134-43. PubMed ID: 24192009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
